-
Lysis Buffer for Rapid Mouse Genotyping
2026-08-26
Build a faster, more consistent mouse genotyping workflow with a lysis buffer designed for tissue digestion and genomic DNA release. This guide connects practical sample-processing choices with insights from colorectal cancer biomarker research while clearly separating validated evidence from optimization recommendations.
-
CD59–JAK2–STAT3 Signaling in Pancreatic Cancer
2026-08-26
A 2026 study identifies CD59 as a tumor cell-intrinsic driver of pancreatic cancer through the JAK2–STAT3–CACNA1D axis. The findings also show that KRAS inhibition can activate this pathway adaptively, supporting combined targeting strategies while highlighting the need for further translational validation.
-
LG 101506 for RXR Signaling Research
2026-08-25
LG 101506 provides a controllable small-molecule entry point for RXR signaling pathway research, with practical workflows spanning nuclear receptor assays, metabolism regulation, and tumor-immunology hypothesis testing. This guide emphasizes dose planning, matched controls, orthogonal readouts, and the limits of translating RBMS1–PD-L1 findings into RXR experiments.
-
Verapamil HCl: A Txnip-Centered Research Framework
2026-08-25
Verapamil HCl is an L-type calcium channel blocker with applications that extend from calcium signaling to bone-remodeling research. This guide explains how to distinguish direct channel effects from Txnip-associated pathway changes and design better translational assays.
-
PRINT: RNA-Mediated Safe-Harbor Transgene Insertion
2026-08-24
The reference study introduces PRINT, an RNA-only strategy that uses avian R2 retroelement proteins to insert transgenes at a multicopy human safe-harbor locus through target-primed reverse transcription. Its results show substantial insertion frequencies in cultured human primary cells while avoiding donor DNA, although locus specificity, junction integrity, delivery, and long-term safety require further validation.
-
Topotecan Workflow for DNA Damage Research
2026-08-24
Build more reproducible Topotecan experiments by connecting concentration selection, time-resolved DNA damage measurements, apoptosis endpoints, and practical formulation controls. The workflow also shows how a radiotracer biodistribution study can inspire better assay controls without overstating evidence across disease areas.
-
Dovitinib and ERK: Designing Better Cancer Assays
2026-08-23
Dovitinib (TKI-258) offers a powerful way to interrogate receptor tyrosine kinase and downstream ERK–STAT signaling in cancer models. This article connects its multitarget profile with IFNγ-driven melanoma apoptosis to improve mechanistic assay design beyond simple viability measurements.
-
Sabutoclax Workflows for Apoptosis Assays
2026-08-22
Sabutoclax is a membrane-permeable pan-Bcl-2 inhibitor for dissecting anti-apoptotic dependence across cancer models. This guide connects concentration-response testing with separate measurements of growth inhibition and cell killing, improving interpretation in vitro and during xenograft translation.
-
PreScission Protease for Nuclear Protein Workflows
2026-08-21
PreScission Protease combines sequence-defined HRV 3C protease activity with low-temperature processing for cleaner fusion-tag removal. This article translates that capability into practical workflows for soluble recombinant proteins, dKeap1–lamin Dm0 interaction studies, and troubleshooting-sensitive nuclear assays.
-
NSC 87877: Reliable Shp2 Inhibitor Workflows
2026-08-20
Learn how NSC 87877 (SKU A4544) can support reproducible Shp2 pathway experiments, from EGF-induced Erk1/2 signaling to viability and cytotoxicity assays. This scenario-based guide separates biochemical potency from cellular response and provides practical formulation, storage, and vendor-selection guidance.
-
M344: Practical HDAC Inhibitor Workflows
2026-08-20
M344 is a cell-permeable histone deacetylase inhibitor for linking chromatin acetylation to proliferation, differentiation, apoptosis, radiation response, and viral latency. This workflow-focused guide covers dose selection, assay controls, solubility, model-specific applications, and troubleshooting for reproducible in vitro and ex vivo studies.
-
Alfuzosin HCl: From Receptor Signal to Assay
2026-08-19
Explore how Alfuzosin HCl links α1-adrenergic pharmacology with gastroretentive formulation science and assay design. This evidence-led guide translates MRI-verified gastric retention into practical decisions for benign prostatic hyperplasia research.
-
PP2A, Autophagy, and Candida Biofilm Resistance
2026-08-19
The reference study identifies protein phosphatase 2A, particularly its PPH21 catalytic subunit, as a regulator of autophagy-linked biofilm formation and antifungal resistance in Candida albicans. By combining PPH21 deletion, rapamycin-mediated autophagy activation, molecular readouts, and an oral infection mouse model, the work connects Atg13 phosphorylation and Atg1 activation with treatment response.
-
ECL Western Blotting Substrate Guide
2026-08-18
ECL Western Blotting Substrate (SKU K2187) is a luminol-based, nonradioactive horseradish peroxidase detection reagent for chemiluminescent Western blot imaging. It is intended for HRP immunoblots using X-ray film or CCD cameras, not for fluorescent or radioisotopic detection workflows.
-
TRAP-1 Reactivates p53Y220C by Induced Proximity
2026-08-18
The preprint reports TRAP-1, a chemical inducer of proximity that brings mutant p53Y220C into a ternary complex with BRD4 and restores transcription of p53-responsive genes. In pancreatic cancer cell models, this mechanism rapidly increased p21 and other target genes while limiting cell growth, highlighting induced proximity as an alternative to simple mutant-protein stabilization.